These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36413741)

  • 41. Impact of Early Palliative Care on End-of-Life Outcomes in Hematologic Malignancies.
    Pelcovits A; Olszewski AJ; Decker D; Guyer D; Leblanc TW; Egan P
    J Palliat Med; 2022 Apr; 25(4):556-561. PubMed ID: 34842462
    [No Abstract]   [Full Text] [Related]  

  • 42. A national profile of kinlessness at the end of life among older adults: Findings from the Health and Retirement Study.
    Plick NP; Ankuda CK; Mair CA; Husain M; Ornstein KA
    J Am Geriatr Soc; 2021 Aug; 69(8):2143-2151. PubMed ID: 33880751
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Latent class analysis identifies three subtypes of aggressive end-of-life care: a population-based study in Taiwan.
    Chen ML; Chen YY; Tang ST
    Eur J Cancer; 2013 Oct; 49(15):3284-91. PubMed ID: 23756054
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Real-World Economic Outcomes During Time on Treatment Among Patients Who Initiated Sunitinib or Pazopanib as First Targeted Therapy for Advanced Renal Cell Carcinoma: A Retrospective Analysis of Medicare Claims Data.
    Vogelzang NJ; Pal SK; Ghate SR; Li N; Swallow E; Peeples M; Zichlin ML; Meiselbach MK; Perez JR; Agarwal N
    J Manag Care Spec Pharm; 2018 Jun; 24(6):525-533. PubMed ID: 29799328
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk Factors for Long-term Mortality and Patterns of End-of-Life Care Among Medicare Sepsis Survivors Discharged to Home Health Care.
    Courtright KR; Jordan L; Murtaugh CM; Barrón Y; Deb P; Moore S; Bowles KH; Mikkelsen ME
    JAMA Netw Open; 2020 Feb; 3(2):e200038. PubMed ID: 32101307
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study.
    Mack JW; Cronin A; Keating NL; Taback N; Huskamp HA; Malin JL; Earle CC; Weeks JC
    J Clin Oncol; 2012 Dec; 30(35):4387-95. PubMed ID: 23150700
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemotherapy Near the End of Life for Chinese Patients with Solid Malignancies.
    Sheng J; Zhang YX; He XB; Fang WF; Yang YP; Lin GN; Wu X; Li N; Zhang J; Zhai LZ; Zhao YY; Huang Y; Zhou NN; Zhao HY; Zhang L
    Oncologist; 2017 Jan; 22(1):53-60. PubMed ID: 27789776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Associations between dementia diagnosis and end-of-life care utilization.
    Luth EA; Manful A; Prigerson HG; Xiang L; Reich A; Semco R; Weissman JS
    J Am Geriatr Soc; 2022 Oct; 70(10):2871-2883. PubMed ID: 35822659
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elevated end-of-life spending: A new measure of potentially wasteful health care spending at the end of life.
    Zhang Y; Gupta A; Nicholson S; Li J
    Health Serv Res; 2023 Feb; 58(1):186-194. PubMed ID: 36303444
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The economic burden of end-of-life care in metastatic breast cancer.
    Bramley T; Antao V; Lunacsek O; Hennenfent K; Masaquel A
    J Med Econ; 2016 Nov; 19(11):1075-1080. PubMed ID: 27248201
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Disparities in Care Management During Terminal Hospitalization Among Adults With Metastatic Cancer From 2010 to 2017.
    Deeb S; Chino FL; Diamond LC; Tao A; Aragones A; Shahrokni A; Yerramilli D; Gillespie EF; Tsai CJ
    JAMA Netw Open; 2021 Sep; 4(9):e2125328. PubMed ID: 34550384
    [TBL] [Abstract][Full Text] [Related]  

  • 52. End-of-life care trajectories among older adults with lung cancer.
    Davidoff AJ; Canavan ME; Prsic E; Saphire M; Wang SY; Presley CJ
    J Geriatr Oncol; 2023 Jan; 14(1):101381. PubMed ID: 36202695
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rising and Falling Trends in the Use of Chemotherapy and Targeted Therapy Near the End of Life in Older Patients With Cancer.
    Fang P; Jagsi R; He W; Lei X; Campbell EG; Giordano SH; Smith GL
    J Clin Oncol; 2019 Jul; 37(20):1721-1731. PubMed ID: 31141431
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chemotherapy Use, End-of-Life Care, and Costs of Care Among Patients Diagnosed With Stage IV Pancreatic Cancer.
    Bao Y; Maciejewski RC; Garrido MM; Shah MA; Maciejewski PK; Prigerson HG
    J Pain Symptom Manage; 2018 Apr; 55(4):1113-1121.e3. PubMed ID: 29241809
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Potentially burdensome end-of-life transitions among nursing home residents with poor-prognosis cancer.
    Lage DE; DuMontier C; Lee Y; Nipp RD; Mitchell SL; Temel JS; El-Jawahri A; Berry SD
    Cancer; 2020 Mar; 126(6):1322-1329. PubMed ID: 31860129
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Timing of end-of-life care discussion with performance on end-of-life quality indicators in ovarian cancer.
    Lopez-Acevedo M; Havrilesky LJ; Broadwater G; Kamal AH; Abernethy AP; Berchuck A; Alvarez Secord A; Tulsky JA; Valea F; Lee PS
    Gynecol Oncol; 2013 Jul; 130(1):156-61. PubMed ID: 23587882
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinicians Who Practice Primarily in Nursing Homes and the Quality of End-of-Life Care Among Residents.
    Ghosh AK; Unruh MA; Yun H; Jung HY
    JAMA Netw Open; 2024 Mar; 7(3):e242546. PubMed ID: 38488792
    [TBL] [Abstract][Full Text] [Related]  

  • 58. End-of-Life Care Intensity Among Adolescent and Young Adult Patients With Cancer in Kaiser Permanente Southern California.
    Mack JW; Chen LH; Cannavale K; Sattayapiwat O; Cooper RM; Chao CR
    JAMA Oncol; 2015 Aug; 1(5):592-600. PubMed ID: 26181778
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Occupational Variation in End-of-Life Care Intensity.
    Hyder JA; Haring RS; Sturgeon D; Gazarian PK; Jiang W; Cooper Z; Lipsitz SR; Prigerson HG; Weissman JS
    Am J Hosp Palliat Care; 2018 Mar; 35(3):377-383. PubMed ID: 28571496
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Contemporary trends in high-dose interleukin-2 use for metastatic renal cell carcinoma in the United States.
    Allard CB; Gelpi-Hammerschmidt F; Harshman LC; Choueiri TK; Faiena I; Modi P; Chung BI; Tinay I; Singer EA; Chang SL
    Urol Oncol; 2015 Nov; 33(11):496.e11-6. PubMed ID: 26210683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.